Neurology and Stroke


Elsdon Storey
Head of Unit 9076 2552 /
9076 2458
Ms. Cheryl Grant PA to Head of Unit 9076 2552 /
9076 2458
A/ Professor
Richard Stark
VMO Neurologist
Dr. Jack Wodak VMO Neurologist
Dr. Bruce Day Staff Specialist, Clinical Neurophysiologist
Dr. John Waterston VMO Neurologist
Dr. Judith Frayne Head, Stroke Service (VMO)
Dr. Richard Gerraty Director, Research & Education,
Stroke Service (VMO)
9076 2058
Dr. Udaya Senaviratne Head, Epilepsy Service (VMO)
Dr. Mark King VMO Neurologist
David Williams
Director Movement Disorders Program,
VMO Neurologist
9076 5231
Dr Tissa Wijeratne VMO/Movement Disorders Program
Ms Sue Varley Parkinson’s Nurse /
Movement Disorders Program
9076 5187
Dr. Rubina Alpitsis Principal Neuropsychologist
Ms Anita Deutsch Nurse Manager, Ward 7 West 9076 3641
Ms Anne-Marie Watson Neurosciences Care Co-ordinator 9076 2000
pager 5333
Mr. Max Cowey Senior Clinical Neurophysiology Scientist
Ms. Belinda Briggs Senior Clinical Neurophysiology Scientist
Mr. Aron Hill Clinical Neurophysiology Scientist
Mr. Rowan Gilligan EEG Technologist
Ms. Linda Buchholz Secretary / Receptionist 9076 2059 /
9076 5075
Ms. Joni Kirk Research Study Coordinator
Ms. Paige Stimpson Research Neuropsychologist (P/T)
Ms. Tracy Henderson Research Neuropsychologist (P/T)
Ms. Kate Tuck Senior Research Clinical Neurophysiologist (P/T)
Ms. Jenny Gapper Stroke Research Nurse
Neurology Registrar & Stroke Registrar
Neurology RMO & Stroke Intern

Description of Service

The Alfred Neurology Unit provides a 24 hour emergency general neurology and stroke service.  Elective general neurology and video EEG-monitoring patients are admitted Monday to Friday. 

The neurophysiology laboratory offers a range of specialised electrophysiology tests to assist in the diagnosis and treatment of neurological conditions.

The tests are performed by a highly experienced and qualified team of scientists, technicians and neurologists.

Please note that in order to make an appointment with our department we must first receive a referral from your doctor including your full name, address and contact number.

Once a referral is received and processed, you will be sent a letter detailing the time and date of your appointment. We provide a service to inpatients and outpatients; including private referrals.

The tests provided include:

  • Electroencephalography (EEG) measures the electrical activity of the brain
  • Nerve conduction study (NCS) and Electromyography (EMG) tests the electrical activity of peripheral nerves and muscles;
  • Long term video EEG monitoring (VEM): 4 day inpatient monitoring for the diagnosis and characterisation of seizure disorders;
  • Tremor study: electrophysiological testing for movement disorders including tremor and myoclonus;
  • Botulinum toxin injection therapy for movement disorders;
  • Visual evoked potentials (VEP) studies the electrical properties of the visual pathways;
  • Somatosensory evoked potentials (SEP) studies the electrical properties of the peripheral and central nervous systems;
  • Quantitative sensory testing (QST) using the Case IV system determines thermal and vibratory sensory thresholds;
  • Autonomic study tests the sympathetic skin response (SSR) and RR interval variation for assessment of sympathetic and parasympathetic nervous system function;
  • Visual field test using the Humphrey visual field tester determines visual field impairment.

The Stroke Unit is a multidisciplinary team specialising in the management of patients who have suffered a stroke or transient ischaemic attack (TIA). 

The Stroke Unit is heavily involved in research and is able to provide, with the friendly cooperation of The Alfred's busy Emergency and Radiology departments, access to intravenous thrombolysis for selected patients with stroke.   

Movement Disorder program

The Movement Disorders Program incorporates the Parkinson's disease and movement disorders outpatient service, dystonia clinic and tremor analysis laboratory.

The team includes three neurologists, the movement disorders fellow, nurse, physiotherapist and several post-graduate students.

The team sees over 1400 patients each year in the clinic and as in-patients.

The clinical team is linked with the clinical and laboratory research team at the Van Cleef Roet Centre for Nervous Disorders, Monash University.

Research Interests and Trial Recruitment  


Clinico-pathological correlations in Parkinson's disease and Parkinsonian syndromes; Genotype-phenotype correlations in Parkinsonian syndromes; Clinical, surgical and pharmacological aspects of Parkinson's disease and Parkinsonism; Biomarkers in Parkinsonism

Recruiting for the following studies:

Dyskinesias in Parkinson's disease

A phase 2 study looking at the effectiveness of a new oral medication used in reducing drug induced involuntary movements in Parkinson's disease. Recruiting patients with Parkinson's disease and dyskinesias.

Identifying the Optimum Target and Predictors of Outcome in Deep Brain Stimulation for Older Patients with Parkinson's Disease

An investigator initiated multicentre study supported by the NHRMC investigating the use of deep brain stimulation surgery in patients older than 67 years. Recruiting patients accepted onto DBS surgical programs with PD and over the age of 67.

Neuroprotection in progressive supranuclear palsy

The only Australian site for a phase 2 multicentre study looking at a novel intranasal medication for treatment of PSP. Recruiting patients with clinically diagnosed PSP.

Biomarkers for Parkinsonism and neurodegeneration

We are investigating the clinical usefulness of measuring protein levels in the cerebrospinal fluid of patients with Parkinson's disease, parkinsonism and dementia to develop a panel of diagnostic tests for these conditions. Recruiting patients with dementia, parkinsonism, PSP, MSA, CBD and Parkinson's disease.


ANCROD ASP-II (Ancrod in Stroke Program ? II): A Randomised, Double-Blind, Placebo ?Controlled Study Of Ancrod (Viprinex TM) in Subjects Beginning Treatment within 6 Hours of the Onset of Acute, Ischemic Stroke. Sponsor: Neurobiological Technologies, Inc., USA . Protocol No: NTI-ASP-0503 (Currently recruiting)


PERFORM Prevention of cerebrovascular and cardiac Events of ischaemic origin with teRutroban in patients with a history oF ischemic stroke or tRansient ischemic attack. The PERFORM Study. An international, randomised, double blind, two parallel group study comparing terutroban 30mg o.d administered orally for a 3 year duration (event driven trial). (Currently recruiting)

ROCKET A Prospective, Randomized, Double-Blind, Double-Dummy, Parallel Group, Multicenter, Event Driven, Non-inferiority Study Comparing the Efficacy and Safety of Once Daily Oral Rivaroxaban (BAY 597939) With Adjusted Dose Oral Warfarin for the Prevention of Stroke and Non Central Nervous System Systemic Embolism in Subjects With Non-Valvular Atrial Fibrillation. (Not currently recruiting - awaiting ethics approval)

ARCH Aortic arch Related Cerebral Hazard

VITATOPS Vitamins To Prevent Stroke: A multicentre, randomised, double-blind, placebo controlled clinical trial examining the efficacy and safety of multi-vitamin therapy in secondary stroke prevention.

PROFESS Prevention Regimen For Effectively avoiding Second Strokes: A double-blind, active and placebo controlled trial of Aggrenox vs. Clopidogrel + aspirin, with and without Micardis (Ends February 2008)

ONTARGET Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial. (Ends November 2007)

TRANSCEND Telmisartan Randomised Assessment in ACE Intolerant Subjects with Cardiovascular Disease (Ends November 2007)  

Department Files

General Information

All Enquiries
Phone 9076 2059
Fax 9076 5075

Stroke Office,
Ward 7 West
Main Ward Block
The Alfred

Neuroscience Department
4th Floor
Centre Block
The Alfred
Phone: (03) 9076-2059
Fax: (03) 9076-5075

Hours Of Service
Clinical Neurophysiology
Monday to Friday
8am to 5pm

Outpatient Information
Clinics are held for general neurology, stroke, epilepsy/first seizure, neurogenetics, movement disorders, neuro-otology (with the ENT2 Unit), and cognitive disorders (with Aged Psychiatry) at Caulfield Hospital.